FTC sues major pharmacy benefit managers over insulin prices
Healthcare Dive - Practice Management
SEPTEMBER 20, 2024
The agency brought action against Caremark, Express Scripts and Optum Rx on Friday, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list price of life-saving insulin drugs.
Let's personalize your content